Home 2015
Archives
FDA Approves Expanded Use of Opdivo in Advanced Lung Cancer
Demonstrates survival benefit in both squamous and non-squamous non-small-cell lung cancer
FDA Approves Optune Device for Newly Diagnosed Glioblastoma
Newly sanctioned to treat just-diagnosed patients, in combination with temozolomide
CDC: Hospitals Doing Better Job of Promoting Breastfeeding
Still, nearly 4 million infants are born each year in U.S., but only 14% in 'baby-friendly' hospitals
USPSTF Recommends CRC Screening for 50- to 75-Year-Olds
Grade A recommendation for 50- to 75-year-olds; individualized decision urged for those age 76 to 85
California Governor Signs Right-to-Die Bill Into Law
Physicians can now prescribe life-ending drugs to terminally ill
FDA OKs Long-Acting Atypical Antipsychotic for Schizophrenia
Aristada (aripiprazole lauroxil) is injected every four-to-six weeks
FDA Approves New Combo Therapy for Melanoma
Yervoy and Opdivo previously approved individually to treat melanoma
FDA Approves Keytruda for Advanced NSCLC
Approved for use with PD-L1 IHC 22C3 pharmDx test
FDA Approves Two New Medications for Diabetes
Tresiba and Ryzodeg approved for use in adults with type 1 and 2 diabetes mellitus
CDC Estimates HIV Prevalence in U.S. Adults From ’07 to ’12
Prevalence estimated at 0.39 percent; 51.9 percent of HIV-infected on antiretroviral tx
